Equities

Denali Therapeutics Inc

Denali Therapeutics Inc

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,0351,336865
Total Receivables, Net--01.23
Total Inventory------
Prepaid expenses303631
Other current assets, total------
Total current assets1,0641,372897
Property, plant & equipment, net727570
Goodwill, net------
Intangibles, net------
Long term investments--0425
Note receivable - long term------
Other long term assets171312
Total assets1,1541,4601,404
LIABILITIES
Accounts payable9.482.794.78
Accrued expenses686753
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0294320
Total current liabilities78364378
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total455464
Total liabilities123418442
SHAREHOLDERS EQUITY
Common stock1.711.691.55
Additional paid-in capital2,1452,0191,608
Retained earnings (accumulated deficit)(1116)(971)(645)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.64(6.89)(2.5)
Total equity1,0311,042962
Total liabilities & shareholders' equity1,1541,4601,404
Total common shares outstanding138136122
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.